tirzepatide hba1c reduction outperforms semaglutide for reduction, weight loss in type 2 diabetes New Dual Incretin Agonist for

Patients should contact their GP if they experience: Persistent vomiting or diarrhoea leading to dehydration Severe abdominal pain Signs of allergic reaction (rash, difficulty breathing, facial swelling) Symptoms of pancreatitis or gallbladder disease Changes in vision Pregnancy should be avoided during treatment, and semaglutide should be discontinued at least two months before planned conception due to limited safety data

As a result, such an imbalance can lead to disorder in osmotic adjustment (Alharbi et al

J.PerkovicV

Vegetarians and individuals over 50 face particularly elevated risk, as do people with digestive conditions affecting nutrient absorption